The only partnership deals that have been executed in Mesoblast history have been 100% positive. Cephalon deal 7 years ago? And JVC ? in Japan for GVHD....
Silvu''s history of partnering is amazing in comparison to any other stem cell company.
IMO the rest of the regen med companies may be waiting for Silvu to lead the way in partnership deals.
Remember no leading stem cell company has partnered or sold out on the cheap yet.
Clock keeps ticking and now were getting closer to phase 3 readouts.... And our market cap keeps decreasing. Kind of an oxymoron
I am long GLTA
No trigger points for the share price, page-28
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |